Objective Data Rather Than Opinion in the Interpretation of the Legitimate Goals of Phase 1 Oncology Trials

ISSN： 0735-7907

Source： Cancer Investigation, Vol.26, Iss.1, 2007-10, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Clinical Trials in Oncology: Strengths and Limitations of Two-Stage Designs

By Schlesselman James Reis Isildinha

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 404-412

Informa Healthcare

Access to resources Recommend Favorite

“Rather one more chemo than one less…”: Oncologists and Oncology Nurses’ Reasons for Aggressive Treatment of Young Adults with Advanced Cancer

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 256-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

FLEX data, KRAS and ERCC1 testing in oncology

By Stebbing Justin

Future Oncology, Vol. 4, Iss. 4, 2008-08 ,pp. : 471-473

Future Medicine

Access to resources Recommend Favorite

Non-Inferiority Trials in Surgical Oncology

By Fueglistaler Philipp Adamina Michel Guller Ulrich

Annals of Surgical Oncology, Vol. 14, Iss. 5, 2007-05 ,pp. : 1532-1539

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials in Oncology and Defining Benefit

The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. : 135-135

John Wiley & Sons Inc

Access to resources Recommend Favorite